Your browser doesn't support javascript.
loading
Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarization.
Mallardo, Domenico; Simeone, Ester; Vanella, Vito; Vitale, Maria Grazia; Palla, Marco; Scarpato, Luigi; Paone, Miriam; De Cristofaro, Teresa; Borzillo, Valentina; Cortellini, Alessio; Sparano, Francesca; Pignata, Sandro; Fiore, Francesco; Caracò, Corrado; Maiolino, Piera; Petrillo, Antonella; Cavalcanti, Ernesta; Lastoria, Secondo; Muto, Paolo; Budillon, Alfredo; Warren, Sarah; Ascierto, Paolo Antonio.
Affiliation
  • Mallardo D; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione "G. Pascale", Naples, Italy.
  • Simeone E; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione "G. Pascale", Naples, Italy.
  • Vanella V; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione "G. Pascale", Naples, Italy.
  • Vitale MG; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione "G. Pascale", Naples, Italy.
  • Palla M; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione "G. Pascale", Naples, Italy.
  • Scarpato L; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione "G. Pascale", Naples, Italy.
  • Paone M; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione "G. Pascale", Naples, Italy.
  • De Cristofaro T; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione "G. Pascale", Naples, Italy.
  • Borzillo V; Radiation Oncology Unit, Istituto Nazionale Tumori - IRCCS -Fondazione "G. Pascale", Naples, Italy.
  • Cortellini A; Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W120HS, UK.
  • Sparano F; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione "G. Pascale", Naples, Italy.
  • Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori - IRCCS -Fondazione "G. Pascale", Naples, Italy.
  • Fiore F; Interventional Radiology Unit, Istituto Nazionale Tumori - IRCCS -Fondazione "G. Pascale", Naples, Italy.
  • Caracò C; Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori - IRCCS - Fondazione "G. Pascale", Naples, Italy.
  • Maiolino P; Hospital Pharmacy, Istituto Nazionale Tumori - IRCCS - Fondazione "G. Pascale", Naples, Italy.
  • Petrillo A; Radiology Division, Istituto Nazionale Tumori - IRCCS - Fondazione "G. Pascale", Naples, Italy.
  • Cavalcanti E; Division of Laboratory Medicine, Istituto Nazionale Tumori - IRCCS -Fondazione "G. Pascale", Naples, Italy.
  • Lastoria S; Nuclear Medicine Unit, Istituto Nazionale Tumori - IRCCS - Fondazione "G. Pascale", Naples, Italy.
  • Muto P; Radiation Oncology Unit, Istituto Nazionale Tumori - IRCCS -Fondazione "G. Pascale", Naples, Italy.
  • Budillon A; Experimental Pharmacology Unit, Istituto Nazionale Tumori - IRCCS - Fondazione "G. Pascale", Naples, Italy.
  • Warren S; NanoString Technologies, Seattle, WA, USA.
  • Ascierto PA; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione "G. Pascale", Naples, Italy. p.ascierto@istitutotumori.na.it.
J Transl Med ; 20(1): 436, 2022 09 30.
Article in En | MEDLINE | ID: mdl-36180872
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Programmed Cell Death 1 Receptor / Melanoma Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Transl Med Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Programmed Cell Death 1 Receptor / Melanoma Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Transl Med Year: 2022 Document type: Article